ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma-Reference-Cited by-同舟云学术

ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma

Published:2017-07 Issue:1 Volume:32 Page:88-100.e6
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Marchesini Matteo,Ogoti Yamini,Fiorini Elena,Aktas Samur Anil,Nezi Luigi,D'Anca Marianna,Storti Paola,Samur Mehmet Kemal,Ganan-Gomez Irene,Fulciniti Maria Teresa,Mistry Nipun,Jiang Shan,Bao Naran,Marchica Valentina,Neri Antonino,Bueso-Ramos Carlos,Wu Chang-Jiun,Zhang Li,Liang Han,Peng Xinxin,Giuliani Nicola,Draetta Giulio,Clise-Dwyer Karen,Kantarjian Hagop,Munshi Nikhil,Orlowski Robert,Garcia-Manero Guillermo,DePinho Ronald A.,Colla Simona

Funder

MD Anderson Cancer Center Leukemia SPORE

Associazione Italiana per la Ricerca sul Cancro

NIH

NCI

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference51 articles.

1. Cytogenetic and clinical marks for defining high-risk myeloma in the context of bortezomib treatment;An;Exp. Hematol.,2014

2. HTSeq – a Python framework to work with high-throughput sequencing data;Anders;Bioinformatics,2015